Patents by Inventor Pieter M. Verbost

Pieter M. Verbost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Progestogen-anti-progestogen regimens
    Publication number: 20030078245
    Abstract: A contraceptive and/or HRT (hormone replacement therapy) kit comprising sequential daily dosage units each containing as the sole contraceptively effective ingredient a progestogen, or as the effective ingredient for HRT a progestogen with or without an estrogen or an estrogen only, and further two or more dosage units comprising an anti-progestogen. The present invention also provides contraceptive and HRT methods comprising administering daily dosage units of a progestogen and anti-progestogen.
    Type: Application
    Filed: November 25, 2002
    Publication date: April 24, 2003
    Inventors: Herman Jan Tijmen Coelingh Bennink, Pieter M. Verbost
  • Progestogen-anti-progestogen regimens
    Patent number: 6506390
    Abstract: A contraceptive and/or HRT (hormone replacement therapy) kit comprising sequential daily dosage units each containing as the sole contraceptively effective ingredient a progestogen, or as the effective ingredient for HRT a progestogen with or without an estrogen or an estrogen only, and further two or more dosage units comprising an anti-progestogen. The present invention also provides contraceptive and HRT methods comprising administering daily dosage units of a progestogen and anti-progestogen.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: January 14, 2003
    Assignee: Akzo Nobel
    Inventors: Herman Jan Tijmen Coelingh Bennink, Pieter M. Verbost
  • Progestogen-anti-progestogen regimens
    Publication number: 20010027189
    Abstract: Disclosed is a contraceptive and/or HRT (hormone replacement therapy) kit comprising sequential daily dosage units each containing as the sole contraceptively effective ingredient of a progestogen, or as effective ingredient for HRT a progestogen with or without an estrogen or an estrogen only, and further two or more dosage units comprising an anti-progestogen. One of the anti-progestogen is administered at the beginning and the others regularly divided throughout the cycle, preferably one only in the middle of the cycle.
    Type: Application
    Filed: January 8, 2001
    Publication date: October 4, 2001
    Inventors: Herman Jan Tijmen Coelingh Bennink, Pieter M. Verbost